Wiley Matthew T.
CIK 0001759703
Chief Commercial Officer
Filings
10
Latest Feb 5, 2026
Issuers covered
2
Showing
10 of 10
Page 1
Track record
4 of 4 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 4 | 75% | +0.6% | +5.2% | +9.4% | -17.3% |
| 90 days | 4 | 100% | +44.3% | +44.2% | +59.9% | +28.7% |
| 180 days | 4 | 100% | +76.1% | +78.0% | +79.1% | +69.5% |
| 365 days | 4 | 100% | +82.6% | +81.8% | +96.2% | +70.8% |
Issuers
Companies where Wiley Matthew T. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| BTAI | Bioxcel Therapeutics, Inc. | 8 | Apr 1, 2025 |
| MNMD | Mind Medicine (Mindmed) Inc. | 2 | Feb 5, 2026 |
All filings
10 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|